Exploratory study of factors affecting poor response in MSI test using EUS-FNAB sample of pancreatic cancer

Exploratory study of factors affecting poor response in MSI test using EUS-FNAB sample of pancreatic cancer - Exploratory study of factors affecting poor response in MSI test using EUS-FNAB sample of pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038203

Enrollment

100

Registered

2019-10-04

Start date

2019-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. age =>20 2. patients undergoing chemotherapy for pancreatic cancer

Exclusion criteria

Exclusion criteria: 1. patients who have difficulty with chemotherapy 2. patients whose participation in the trial was judged to be inappropriate by the investigator

Design outcomes

Primary

Measure	Time frame
factors related to poor response in MSI test	—

Secondary

Measure	Time frame
proportion of MSI-High proportion of MSI test failure accuracy, sensitivity, specificity, positive predictive value, negative predictive value of EUS-FNAB for malignant diagnosis tissue sampling rate adverse events	—

Countries

Japan

Contacts

Public ContactMasafumi Watanabe

Kitasato University School of Medicine Department of Gastroenterology

m.wata@kitasato-u.ac.jp042-778-8111

Outcome results